PATENT CLAIM ANALYSIS

Application Number: 16194061
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "533000"]

Abstract:
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders.

Claim (Index 12):
A method of treating a subject with hepatic encephalopathy who has previously been administered an initial dosage of glyceryl tri-[4-phenylbutyrate], said method comprising:\n a) measuring a fasting blood ammonia level for the subject; b) comparing the fasting blood ammonia level to the upper limit of normal for blood ammonia level and c) administering an adjusted dosage of the glyceryl tri-[4-phenylbutyrate] that is greater than the initial dosage if the fasting blood ammonia level is greater than half the upper limit of normal for blood ammonia level.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.29268
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15687132', '15944422', '15944432', '15457643', '15944411']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8111970271921702
- 35 USC 102 Novelty (BERT): 0.6091862566058207
- Combined Prediction Score: 0.7909959501335353
- Mean Citation Score: 588.1696900000002
- Max Citation Score: 589.74805
- Similarity Product: 452.4016911121965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test